🇺🇸 FDA
Patent

US 6156723

Compositions comprising inhibitors of estrogen response

expired A61KA61K31/35A61K31/52

Quick answer

US patent 6156723 (Compositions comprising inhibitors of estrogen response) held by The Regents of the University of California expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/35, A61K31/52, A61K31/55